SU\G(𝔸)/K·U

Angela Huttner

Follow

Generating author description...

All published works
Action Title Year Authors
+ PDF Chat Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability 2023 Angela Huttner
Sélidji Todagbé Agnandji
Olivier Engler
Jay W. Hooper
Steve Kwilas
Keersten M. Ricks
Tamara L. Clements
Hulda R. Jónsdóttir
Sravya Sowdamini Nakka
Sylvia Rothenberger
+ PDF Chat Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 2018 Angela Huttner
Sélidji Todagbé Agnandji
Christophe Combescure
José F. Fernandes
Emmanuel B. Bache
Lumeka Kabwende
Francis M. Ndungu
Jessica S. Brosnahan
Thomas P. Monath
Barbara Lemaître
Common Coauthors
Coauthor Papers Together
José F. Fernandes 2
Jenna Anderson 2
Floriane Auderset 2
Tom H. M. Ottenhoff 2
Patricia Njuguna 2
Donata Medaglini 2
Mark Page 2
Jessica S. Brosnahan 2
Sylvia Rothenberger 2
Rafi Ahmed 2
Fiona O’Rourke 2
Helder I. Nakaya 2
Claire‐Anne Siegrist 2
Peter G. Kremsner 2
Marylyn M. Addo 2
Ali M. Harandi 2
Luisa Borgianni 2
Thomas P. Monath 2
Sheri Dubey 2
Alice Gerlini 2
Gianni Pozzi 2
Francesco Santoro 2
Olivier Engler 2
Stephan Becker 2
Francis M. Ndungu 2
David Pejoski 2
Sanjeev Krishna 2
Sélidji Todagbé Agnandji 2
Annalisa Ciabattini 2
Donald Gray Heppner 2
Marie-Paule Kiény 2
Jasmine Portmann 1
Sravya Sowdamini Nakka 1
Tamara L. Clements 1
Emmanuel B. Bache 1
Olivier Lapujade 1
Simone Lucchesi 1
Philip Bejon 1
Verena Krähling 1
Patricia Fast 1
Steve Kwilas 1
Vasee Moorthy 1
Christophe Combescure 1
Philip Bejon 1
Stéphane Grillet 1
Verena Kra ̈hling 1
Suzanne van Veen 1
Barbara Lemaître 1
Marie ̈lle C. Haks 1
Eleonora Vianello 1
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon 2010 Pierre Becquart
Nadia Wauquier
Tanel Mahlakõiv
Dieudonné Nkoghe
Cindy Padilla
Marc Souris
Benjamin Ollomo
Jean‐Paul Gonzalez
Xavier de Lamballerie
Mirdad Kazanji
 1
+ PDF Chat A Recombinant Vesicular Stomatitis Virus Ebola Vaccine 2015 Jason A. Regules
John H. Beigel
Kristopher Paolino
Jocelyn Voell
Amy R. Castellano
Zonghui Hu
P. Rubio Muñoz
James E. Moon
Richard C. Ruck
Jason W. Bennett
 1
+ PDF Chat Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study 2017 D. Gray Heppner
Tracy Kemp
Brian K. Martin
W. Jay Ramsey
Richard Nichols
Emily J. Dasen
Charles J. Link
Rituparna Das
Zhi Jin Xu
Eric Sheldon
 1
+ PDF Chat Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study 2018 Angela Huttner
Sélidji Todagbé Agnandji
Christophe Combescure
José F. Fernandes
Emmanuel B. Bache
Lumeka Kabwende
Francis M. Ndungu
Jessica S. Brosnahan
Thomas P. Monath
Barbara Lemaître
 1
+ Correlates of vaccine-induced protective immunity against Ebola virus disease 2018 Donata Medaglini
Francesco Santoro
Claire‐Anne Siegrist
 1
+ PDF Chat Ebola Virus Infection Associated with Transmission from Survivors 2018 Saskia den Boon
Barbara J. Marston
Tolbert Nyenswah
Amara Jambai
Moumié Barry
Sakoba Keïta
Kara Durski
Schabbethai S. Senesie
Devin Perkins
Anita Shah
 1